EUVIMEDEUVIMED entdecken
Crossref

Predicting Decompensation in Unresectable Hepatocellular Carcinoma on Atezolizumab Plus Bevacizumab: The ARTE Score

Lorenzo Canova, Eleonora Alimenti, Lorenzo Argiento, Giuseppe Cabibbo, Francesco Tovoli, Emanuela Di Giacomo, Peter R Galle, Ciro Celsa, Matthias Pinter, Thomas U Marron, Caterina Vivaldi, Andrea Dalbeni und 29 weitere

Clinical Gastroenterology and Hepatology · 2026-05

DOI: 10.1016/j.cgh.2026.04.033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-05. Verfasst von Lorenzo Canova und 40 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatology, San Giuseppe Hospital, IRCCS MultiMedica, Milan, Italy. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Hepatic decompensation is a major event in patients with unresectable hepatocellular carcinoma (uHCC) treated with systemic therapy. Early identification of high-risk patients is essential. Aim of the study was to develop a simple score to predict decompensation in patients treated with atezolizumab plus bevacizumab (AB). METHODS This study enrolled 453 patients from the ARTE database (AB first-line, Child-Pugh A). External validation cohort included 292 patients from the AB-real database. Independent predictors derived from Cox regression were combined into a weighted score and operationalized as a point-based algorithm. Patients were then stratified into low-, intermediate-, and high-risk groups. RESULTS In the ARTE database, 74 (16.3%) patients developed hepatic decompensation (median follow-up 14 months). Neoplastic portal vein thrombosis (HR 1.97, 95%CI 1.20-3.23, p=0.007), elevated bilirubin (HR 2.61, 95%CI 1.52-4.47, p

Schlagwörter

Stichwörter der Autor:innen

AtezolizumabBevacizumabHCCNeoplastic Portal Vein ThrombosisPortal Hypertension

Autor:innen und Institutionen

  • Division of Hepatology, San Giuseppe Hospital, IRCCS MultiMedica, Milan, Italy.
  • Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, CRC "A. M. and A. Migliavacca" Center for Liver Di…
  • Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Gastroenterology and Hepatology Unit, Department of Health Promotion, Mother and Child Care, Internal Medicine & Medical Specialties, University of Palermo, Palermo, Italy.
  • Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Unit of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Ital…
  • Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom.

Förderung

  • Ministry of Health

Zitieren

APA

Canova, L., Alimenti, E., Argiento, L., Cabibbo, G., Tovoli, F., Di Giacomo, E., Galle, P. R., Celsa, C., Pinter, M., Marron, T. U., Vivaldi, C., Dalbeni, A., Marra, F., Palloni, A., Lonardi, S., Ponziani, F. R., Federico, P., Saeed, A., Pillai, A., …, & Iavarone, M. (2026). Predicting Decompensation in Unresectable Hepatocellular Carcinoma on Atezolizumab Plus Bevacizumab: The ARTE Score. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2026.04.033

Vancouver

Canova L, Alimenti E, Argiento L, Cabibbo G, Tovoli F, Di Giacomo E, et al. Predicting Decompensation in Unresectable Hepatocellular Carcinoma on Atezolizumab Plus Bevacizumab: The ARTE Score. Clinical Gastroenterology and Hepatology. 2026. doi:10.1016/j.cgh.2026.04.033

BibTeX
@article{Canova2026,
  author = {Canova, Lorenzo and Alimenti, Eleonora and Argiento, Lorenzo and Cabibbo, Giuseppe and Tovoli, Francesco and Di Giacomo, Emanuela and Galle, Peter R and Celsa, Ciro and Pinter, Matthias and Marron, Thomas U and Vivaldi, Caterina and Dalbeni, Andrea and Marra, Fabio and Palloni, Andrea and Lonardi, Sara and Ponziani, Francesca Romana and Federico, Piera and Saeed, Anwaar and Pillai, Anjana and Pressiani, Tiziana and Camera, Silvia and Svegliati-Baroni, Gianluca and Manfredi, Giulia Francesca and Lani, Lorenzo and von Felden, Johann and Ulahannan, Susanna and Ielasi, Luca and De Lorenzo, Stefania and Mazzarelli, Chiara and Sacco, Rodolfo and Rohlen, Natascha and Silletta, Marianna and Toniutto, Pierluigi and Ascari, Sara and Fulgenzi, Claudia and Scheiner, Bernhard and Crowley, Fionnuala and Cerini, Federica and Lampertico, Pietro and Pinato, David James and Iavarone, Massimo},
  title = {Predicting Decompensation in Unresectable Hepatocellular Carcinoma on Atezolizumab Plus Bevacizumab: The ARTE Score},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  doi = {10.1016/j.cgh.2026.04.033}
}
Kostenlos starten →